Claims
- 1. A compound of Formula I or of Formula II
- 2. A compound of Formula I or of Formula II
- 3. A compound of Formula I or of Formula II
- 4. A compound of Formula I or of Formula II
- 5. A compound of Formula I or of Formula II
- 6. A compound of Formula I or of Formula II
- 7. A compound of Formula I or of Formula II
- 8. A compound of Formula I or of Formula II
- 9. The compound according to claim 8, wherein:
R1 is Me; R3 is H, F, Br, or CF3; R4 is Cl, Br, or CF3; and R5 is H, Br, or CF3.
- 10. The compound according to claim 9, wherein:
R1, R6, and R7 are each Me; R3 is H or F; R4 is Cl or Br; and R5 is H or Br.
- 11. The compound according to claim 8, wherein:
R1 is F, Cl, Br, or CF3; R3, R4, and R5 are each independently H, F, Cl, Br, or CF3; and R6 and R7 are each independently Me or Et.
- 12. The compound according to claim 8, wherein:
R1 is Cl, Br, or CF3; R3 is H, F, Br, or CF3; and R5 is H, Br, or CF3.
- 13. The compound according to claim 8, wherein:
R1 is Cl or Br; R3 is H or F; R5 is H or Br; R6 and R7 are each Me.
- 14. A compound selected from the group consisting of:
(a) 2′-bromo-3′-chloro-5′-dimethylamino-6′-methylphen-1′-yl-2-iminoimidazolidine; (b) 3′-bromo-5′-diethylamino-6′-methylphen-1′-yl-2-iminoimidazolidine; (c) 3′-bromo-5′-dimethylamino-6′-methylphen-1′-yl-2-iminoimidazolidine; (d) 3′-chloro-5′-dimethylamino-6′-methylphen-1′-yl-2-iminoimidazolidine; (e) 2′-3′-dibromo-5′-dimethylamino-6′-methylphen-1′-yl-2-iminoimidazolidine; (f) 2′-chloro-3′-dimethylaminophen-1′-yl-2-iminoimidazolidine; (g) 4′-bromo-2′-chloro-3′-dimethylaminophen-1′-yl-2-iminoimidazolidine; (h) 2′-bromo-6′-chloro-5′-dimethylaminophen-1′-yl-2-iminoimidazolidine; and (i) 5′-bromo-2′-chloro-3′-dimethylaminophen-1′-yl-2-iminoimidazolidine, or a tautomer thereof or a corresponding pharmacologically-compatible salt thereof.
- 15. A compound selected from the group consisting of:
(a) 2′-bromo-3′-chloro-5′-dimethylamino-6′-methylphen-1′-yl-2-iminoimidazolidine; (b) 3′-bromo-5′-dimethylamino-6′-methylphen-1′-yl-2-iminoimidazolidine; (c) 3′-chloro-5′-dimethylamino-6′-methylphen-1′-yl-2-iminoimidazolidine; and (d) 2′-3′-dibromo-5′-dimethylamino-6′-methylphen-1′-yl-2-iminoimidazolidine, or a tautomer thereof or a corresponding pharmacologically-compatible salt thereof.
- 16. 3′-chloro-5′-dimethylamino-6′-methylphen-1′-yl-2-iminoimidazolidine, or a tautomer thereof or a corresponding pharmacologically-compatible salt thereof.
- 17. 2′-chloro-3′-dimethylaminophen-1′-yl-2-iminoimidazolidine, or a tautomer thereof or a corresponding pharmacologically-compatible salt thereof.
- 18. 4′-bromo-2′-chloro-3′-dimethylaminophen-1′-yl-2-iminoimidazolidine, or a tautomer thereof or a corresponding pharmacologically-compatible salt thereof.
- 19. The compound of Formula I or of Formula II according to one of claims 1 to 8, wherein the compound of Formula I or of Formula II is an imino-imidazolidine.
- 20. The compound of Formula I or of Formula II according to one of claims 1 to 8, wherein the compound of Formula I or of Formula II is an amino-imidazoline.
- 21. A pharmaceutical composition comprising an effective amount of a compound of Formula I or of Formula II according to one of claims 1 to 18 and an inert carrier or diluent.
- 22. A pharmaceutical composition comprising an effective amount of a compound of Formula I or of Formula II according to claim 19 and an inert carrier or diluent.
- 23. A pharmaceutical composition comprising an effective amount of a compound of Formula I or of Formula II according to claim 20 and an inert carrier or diluent.
Priority Claims (1)
Number |
Date |
Country |
Kind |
100 51 005.1 |
Oct 2000 |
DE |
|
RELATED APPLICATIONS
[0001] This application is a continuation of U.S. application Ser. No. 09/976,917, filed Oct. 12, 2001, now U.S. Pat. No. ______. Benefit under 35 U.S.C. § 119(e) of prior U.S. provisional application Serial No. 60/248,172, filed Nov. 14, 2000, is hereby claimed. Both of these applications are hereby incorporated by reference in their entireties.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60248172 |
Nov 2000 |
US |
Continuations (1)
|
Number |
Date |
Country |
Parent |
09976917 |
Oct 2001 |
US |
Child |
10349993 |
Jan 2003 |
US |